Mitochondria-targeted peptides studied for bioenergetics and cardiolipin.
Mitochondrial peptides are studied as regulators of cellular energy production — both the mitochondria-derived peptides encoded within the mitochondrial genome and synthetic compounds that target the inner membrane. The unifying interest is bioenergetic efficiency and resilience under metabolic stress.
Research endpoints include cardiolipin stabilization and electron-transport efficiency, exercise capacity and metabolic flexibility, and inherited or acquired mitochondrial dysfunction such as mitochondrial myopathy, Barth syndrome, and heart failure. The area overlaps closely with aging and metabolic research.
They include mitochondria-derived peptides encoded in the mitochondrial genome and synthetic compounds targeting the inner membrane, studied for bioenergetic efficiency.
Research looks at cardiolipin stabilization, electron-transport efficiency, exercise capacity and metabolic flexibility, and mitochondrial dysfunction.
Models include mitochondrial myopathy, Barth syndrome, and heart failure, with substantial overlap into aging and metabolic research.
How to weigh this evidence
Preclinical, observational, and randomized findings carry very different weight. The evidence hierarchy shows how to rank what you read before drawing conclusions.